نتایج جستجو برای: mesenchymal stem cell transplantation

تعداد نتایج: 1905321  

Journal: :iranian journal of blood and cancer 0
soheila zareifar associate professor of pediatric hematology-oncology, department of pediatrics, shiraz university of medical sciences, shiraz, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences) babak abdolkarimi assistant professor of pediatric hematology-oncology, lorestan university of medical sciences, khoramabad, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی لرستان (lorestan university of medical sciences) mohamadreza bordbar associate professor of pediatric hematology-oncology, department of pediatrics, shiraz university of medical sciences, shiraz, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences) mehran karimi professor of pediatric hematology-oncology, department of pediatrics, shiraz university of medical sciences, shiraz, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences) fazl saleh fellowship of pediatric hematology-oncology, department of pediatrics, shiraz university of medical sciences, shiraz, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences) omidreza zekavat associate professor of pediatric hematology-oncology, department of pediatrics, shiraz university of medical sciences, shiraz, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences)

background: burkitt lymphoma is a common subtype of non-hodgkin lymphoma in children. it has a rapid and aggressive clinical course with frequent involvement of bone marrow and central nervous system. systemic chemotherapy is the mainstay of the treatment for this malignancy in children. in this systematic review, we discuss autologous and allogeneic hematopoietic stem cell transplantation (hsc...

Journal: :physiology and pharmacology 0
mohammad amin edalatmanesh biotechnology & tissue engineering research center, ferdowsi university of mashhad, mashad, iran ahmad reza bahrami institute of biotechnology morteza behnam rasuli dept. biology, faculty of science, ferdowsi university of mashhad, mashad, iran ali moghimi dept. biology, faculty of science, ferdowsi university of mashhad, mashad, iran maryam moghadam matin fatemeh naseri dept. biology, faculty of science, ferdowsi university of mashhad, mashad, iran

introduction: as an inherited neurodegenerative disease, huntington's disease is accompanied with wide neuronal degeneration in neostriatum and neocortex. progress of the disease causes disabling clinical effects on movements, recognition and physiology of the body, and finally results in death. at this stage of knowledge we are, there is no effective therapeutic strategy for diminishing t...

Journal: :iranian journal of public health 0
rowshanak abbasi bagher larijani ensieh nasli esfahani mostafa ghor­bani camelia rambod ramin heshmat

background: stem cell therapy is a new treatment option for different diseases. the aim of this systematic review is assessing the articles that focus on sct in iran and evaluate the amount of their success, failure and complication. methods: systematic search was conducted for finding english and persian papers (controlled trials and cohort studies with follow up) published before march 2015. ...

Journal: :international journal of hematology-oncology and stem cell research 0
mohammad vaezi hematology- oncology and stem cell transplantation research center, tehran university of medical sciences davoud oulad dameshghi qom university of medical sciences maryam souri hematology- oncology and stem cell transplantation research center, tehran university of medical sciences seyed amin setarehdan hematology- oncology and stem cell transplantation research center, tehran university of medical sciences kamran alimoghaddam hematology- oncology and stem cell transplantation research center, tehran university of medical sciences ardeshir ghavamzadeh hematology- oncology and stem cell transplantation research center, tehran university of medical sciences

the increased risk of hemolytic reactions and erythrocyte recovery delay in abo incompatible hematopoietic stem cell transplantation (hsct) is well established. effects of abo incompatibility on transplantation outcomes is evaluated in this study. we prospectively followed 501 patients undergoing allogeneic stem cell transplantation according to abo compatibility groups of minor, major and bidi...

Journal: :FEBS Letters 2021

Stem cell-based therapy has been highlighted as a potential avenue to promote tissue regeneration, where stimulation of stem cells differentiate into the targeted cell type is essential. One factors that induce their surrounding microenvironment. In this study, correlation between mild reductant and early osteogenic commitment was evaluated. A surface-reducing microenvironment significantly sil...

Journal: :Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 2010
Yun-Tao Wang Xiao-Tao Wu Feng Wang

Intervertebral disc degeneration is a primary cause of low back pain and has a high societal cost. The pathological mechanism by which the intervertebral disc degenerates is largely unknown. Cell-based therapy especially using bone marrow mesenchymal stem cells as seeds for transplantation, although still in its infancy, is proving to be a promising, realistic approach to intervertebral disc re...

2012
Masaaki Kitada Mari Dezawa

Cell transplantation is a strategy with great potential for the treatment of Parkinson's disease, and many types of stem cells, including neural stem cells and embryonic stem cells, are considered candidates for transplantation therapy. Mesenchymal stem cells are a great therapeutic cell source because they are easy accessible and can be expanded from patients or donor mesenchymal tissues witho...

Journal: :Current opinion in rheumatology 2007
Alan Tyndall Daniel E Furst

PURPOSE OF REVIEW Provides an update of hematopoietic stem cell transplantation for systemic sclerosis from phase I/II studies and prospective randomized phase III trials, and introduces the concept of mesenchymal stem cells as potential therapy for autoimmune disease. RECENT FINDINGS Around 170 transplanted systemic sclerosis patients are registered in Europe. Most received autologous, perip...

Journal: :Journal of autoimmunity 2008
Nader G Abraham Ming Li Luca Vanella Stephen J Peterson Susumu Ikehara David Asprinio

Increase in endothelial cell sloughing and diminished function of endothelial stem cell progenitors in diabetic subjects are well known phenomena. We hypothesized that transplantation of bone marrow stem cells (BMSCs) including mesenchymal stem cells but not limited to CD34(+) stem cells into type 2 diabetic ob mice would restore insulin sensitivity and glucose tolerance. This approach, when co...

2015
Noriko Itaba Yoshiaki Matsumi Kaori Okinaka An Afida Ashla Yohei Kono Mitsuhiko Osaki Minoru Morimoto Naoyuki Sugiyama Kazuo Ohashi Teruo Okano Goshi Shiota

Mesenchymal stem cells (MSCs) are an attractive cell source for cell therapy. Based on our hypothesis that suppression of Wnt/β-catenin signal enhances hepatic differentiation of human MSCs, we developed human mesenchymal stem cell-engineered hepatic cell sheets by a small molecule compound. Screening of 10 small molecule compounds was performed by WST assay, TCF reporter assay, and albumin mRN...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید